These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 14790788)

  • 1. The competitive inhibition of uricase activity by 8-azaguanine and by 8-azaxanthine.
    NORRIS ER; ROUSH A
    Arch Biochem; 1950 Oct; 28(3):465-6. PubMed ID: 14790788
    [No Abstract]   [Full Text] [Related]  

  • 2. Potent competitive uricase inhibitors--2,8-diazahypoxanthine and related compounds.
    Iwata H; Yamamoto I; Goda E; Morita K; Nakamura M
    Biochem Pharmacol; 1973 Sep; 22(18):2237-45. PubMed ID: 4733677
    [No Abstract]   [Full Text] [Related]  

  • 3. The inhibition of uricase by xanthine.
    VAN PILSUM JF
    J Biol Chem; 1953 Oct; 204(2):613-21. PubMed ID: 13117835
    [No Abstract]   [Full Text] [Related]  

  • 4. Action of 8-azaguanine and 8-azaxanthine on Pseudomonas aeruginosa.
    Bergmann F; Ungar-Waron H; Kwietny-Govrin H
    Biochem J; 1964 May; 91(2):270-6. PubMed ID: 4953816
    [No Abstract]   [Full Text] [Related]  

  • 5. Oxygen poisoning; the effect of high oxygen pressure upon enzymes; uricase, xanthine oxidase, and alpha-amino acid oxidase.
    STADIE WC; HAUGAARD N
    J Biol Chem; 1945; 161():181-8. PubMed ID: 21005727
    [No Abstract]   [Full Text] [Related]  

  • 6. Colorimetric assays for 8-azaguanine and 8-azaxanthine.
    Saslaw LD; Chaney NA; Waravdekar VS
    Anal Biochem; 1967 Oct; 21(1):147-9. PubMed ID: 6062769
    [No Abstract]   [Full Text] [Related]  

  • 7. Influences of anticancer agents on the activities of liver catalase, uricase, and xanthine oxidase in normal and tumor-bearing mice.
    HANO K; IWATA H; AKASHI A
    Gan; 1963 Mar; 54():47-58. PubMed ID: 13952572
    [No Abstract]   [Full Text] [Related]  

  • 8. [Urate oxidase from pig liver: biochemical and immunological properties].
    Surina TIa; Cherniavskaia MA; Maksimova AS; Kagan AS; Kachkin AP; Levi EV
    Prikl Biokhim Mikrobiol; 1978; 14(4):533-42. PubMed ID: 724662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMR metabolic profiling of Aspergillus nidulans to monitor drug and protein activity.
    Forgue P; Halouska S; Werth M; Xu K; Harris S; Powers R
    J Proteome Res; 2006 Aug; 5(8):1916-23. PubMed ID: 16889413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the inhibition of phage production by 2-thiouracil and 8-azaguanine in an induced lysogenic Bacillus megaterium.
    JEENER R; HAMERS-CASTERMAN C; MAIRESSE N
    Biochim Biophys Acta; 1959 Sep; 35():166-79. PubMed ID: 14406990
    [No Abstract]   [Full Text] [Related]  

  • 11. UTILIZATION OF 8-AZAPURINES BY YEASTS.
    HARRIS G; MACWILLIAM IC
    Biochim Biophys Acta; 1965 Feb; 95():205-8. PubMed ID: 14293695
    [No Abstract]   [Full Text] [Related]  

  • 12. Uricase formulated with polyethylene glycol (uricase-PEG 20): biochemical rationale and preclinical studies.
    Bomalaski JS; Holtsberg FW; Ensor CM; Clark MA
    J Rheumatol; 2002 Sep; 29(9):1942-9. PubMed ID: 12233890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of plasma urate levels in the cockerel with polyethylene glycol-uricase.
    Abuchowski A; Karp D; Davis FF
    J Pharmacol Exp Ther; 1981 Nov; 219(2):352-4. PubMed ID: 7288624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on uricase].
    LEONE E
    Arch Sci Biol (Bologna); 1955; 39(6):605-11. PubMed ID: 13303777
    [No Abstract]   [Full Text] [Related]  

  • 15. The mechanism of the action of uricase.
    BENTLEY R; NEUBERGER A
    Biochem J; 1952 Dec; 52(4):694-9. PubMed ID: 13018303
    [No Abstract]   [Full Text] [Related]  

  • 16. Purification and properties of solubilized uricase.
    HUDSON PB; LONDON M
    Biochim Biophys Acta; 1956 Aug; 21(2):290-8. PubMed ID: 13363909
    [No Abstract]   [Full Text] [Related]  

  • 17. [Absence of uricase in the Testudo graeca liver].
    RICCERI G
    Arch Sci Biol (Bologna); 1952; 36(1):23-31. PubMed ID: 14934486
    [No Abstract]   [Full Text] [Related]  

  • 18. Specific resistance to 8-azaguanine in cells with normal hypoxanthine phosphoribosyltransferase (HPRT) activity: the role of guanine deaminase.
    Meyers MB; Shin S
    Cytogenet Cell Genet; 1981; 30(2):118-28. PubMed ID: 7273856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xanthine dehydrogenase activity in starved-refed rats treated with 8-azaguanine.
    Mitidieri E; Affonso OR; Ribeiro LP
    Acta Biol Med Ger; 1974; 32(6):695-9. PubMed ID: 4420822
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacodynamics of intravenous PEGylated recombinant mammalian urate oxidase in patients with refractory gout.
    Sundy JS; Ganson NJ; Kelly SJ; Scarlett EL; Rehrig CD; Huang W; Hershfield MS
    Arthritis Rheum; 2007 Mar; 56(3):1021-8. PubMed ID: 17328081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.